Heinrich, N.* et al. Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): An open-label, dose-expansion, randomised, controlled, phase 1b/2a trial. Lancet Microbe 6:100952 (2025)
Ramsheh, M.Y.* et al. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: A bacterial 16S rRNA gene sequencing and host transcriptomic analysis. Lancet Microbe 2, e300-e310 (2021)